Spero Therapeutics Inc (NASDAQ:SPRO) traded at $2.94 at close of the session on Friday, June 20 and made an upward move of 3.02% on its previous day’s price.
Looking at the stock we see that its previous close was $5.00 and the beta (5Y monthly) reads 1.308 with the day’s price range being $2.87 – $3.02. In terms of its 52-week price range, SPRO has a high of $3.06 and a low of $0.51. The company’s stock has gained about 343.99% over that past 30 days.
Spero Therapeutics Inc has a market cap of $168.85 million and is expected to release its quarterly earnings report on 2025-May-13.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the Spero Therapeutics Inc (SPRO) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 32 off its SMA20 and 0.06 from its 50-day simple moving average. The beta value is 212.47%, while the average true range (ATR) is currently pointing at -74.62%.
Coming back to Spero Therapeutics Inc (NASDAQ:SPRO), we note that the average 3-month trading volume was 0.53, while that of the preceding 10-day period stands at 2.2 million. Current shares outstanding are 55.90 million.
The insiders hold 33.16% of the company’s shares while institutions hold 20.66%. The data shows that short shares as of 2025-05-30, stood at 3.48 million at a short ratio of 0.35. This represents a 760.00 short interest in shares outstanding on 2025-05-30. Shares short rose in May from the previous month at 0.65 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 135.94% up in year-to-date price movement.
